CSIMarket
 


Scynexis inc   (SCYX)
Other Ticker:  
 
 

SCYX's Net Income Growth by Quarter and Year

Scynexis Inc 's Net Income results by quarter and year




SCYX Net Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - -42.71 -14.46 1.94
III Quarter September - 0.91 -7.94 0.35
II Quarter June 1.66 -6.38 -8.40 -10.76
I Quarter March -4.68 -7.00 -22.91 -4.00
FY   -3.02 -55.18 -53.71 -12.47



SCYX Net Income second quarter 2021 Y/Y Growth Comment
Scynexis inc in the second quarter achieved Net Income of $ 1.66 millions compare to net loss recorded in same quarter a year ago.

According to the results reported in the second quarter, Scynexis Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Scynexis Inc ' s Net Income no change of % ranks overall at the positon no. 0 in the second quarter.




SCYX Net Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Scynexis Inc 's second quarter 2021 Net Income $ 1.66 millions SCYX's Income Statement
Scynexis Inc 's second quarter 2020 Net Income $ -6.38 millions Quarterly SCYX's Income Statement
New: More SCYX's historic Net Income Growth >>


SCYX Net Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - 454.29 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Scynexis Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
452.71 % 447.35 % 441.99 %
(Dec 31 2018)  


SCYX's II. Quarter Q/Q Net Income Comment
This turnaround II. Quarter 2021where Scynexis inc published Net Income of $ 1.66 millions could is inception of better results.Scynexis inc announced in the II. Quarter 2021 Net Income of $ 1.66 millions compare to net loss recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Scynexis inc achieved highest sequential Net Income growth. While Scynexis Inc 's Net Income growth quarter on quarter, overall rank is 0.


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Income Q/Q Growth Statistics
High Average Low
452.71 % 447.35 % 441.99 %
(Dec 31 2018)  


SCYX's II. Quarter Q/Q Net Income Comment
Improvement II. Quarter 2021where Scynexis inc delivered Net Income of $ 1.66 millions may is inception of positive business climet.Scynexis inc announced in the II. Quarter 2021 Net Income of $ 1.66 millions compare to net loss recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Scynexis inc achieved highest sequential Net Income growth. While Scynexis Inc 's Net Income growth quarter on quarter, overall rank is 0.


Scynexis Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
Cumulative Net Income 12 Months Ending $ -44.82 $ -52.86 $ -55.19 $ -26.93 $ -35.78
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Scynexis Inc ' has realized cumulative trailing twelve months net loss of $ -45 millions in the Jun 30 2021 period.

Scynexis inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Scynexis Inc ' has realized cumulative trailing twelve months net loss of $ -45 millions in the Jun 30 2021 period.

Scynexis inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
SCYX's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for SCYX's Competitors
Net Income Growth for Scynexis Inc 's Suppliers
Net Income Growth for SCYX's Customers

You may also want to know
SCYX's Annual Growth Rates SCYX's Profitability Ratios SCYX's Asset Turnover Ratio SCYX's Dividend Growth
SCYX's Roe SCYX's Valuation Ratios SCYX's Financial Strength Ratios SCYX's Dividend Payout Ratio
SCYX's Roa SCYX's Inventory Turnover Ratio SCYX's Growth Rates SCYX's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Jun 30 2021 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2021
Eli Lilly And Company-1.54%$ -1.544 millions
Bio rad Laboratories Inc -5.41%$ -5.413 millions
Corcept Therapeutics Inc-6.37%$ -6.368 millions
Zynex Inc-6.93%$ -6.927 millions
Pacific Health Care Organization Inc-11.14%$ -11.144 millions
Lhc Group Inc-19.11%$ -19.114 millions
Tenax Therapeutics Inc-20.01%$ -20.010 millions
Apollo Medical Holdings Inc -26.51%$ -26.507 millions
Reynolds Consumer Products Inc -28.57%$ -28.571 millions
Msa Safety Inc-30.27%$ -30.267 millions
Chemed Corporation-31.16%$ -31.156 millions
Supernus Pharmaceuticals inc -31.56%$ -31.560 millions
Co diagnostics Inc -34.79%$ -34.787 millions
Biogen Inc -36.17%$ -36.166 millions
Sunlink Health Systems Inc-39.62%$ -39.616 millions
Petmed Express Inc-43.00%$ -42.997 millions
The Pennant Group Inc -43.07%$ -43.071 millions
Neurocrine Biosciences Inc -46.86%$ -46.859 millions
Hill rom Holdings Inc -47.60%$ -47.604 millions
Incyte Corp-48.52%$ -48.516 millions
Merck and Co Inc -48.64%$ -48.638 millions
Molecular Templates Inc -50.04%$ -50.042 millions
Meridian Bioscience Inc -57.58%$ -57.578 millions
Healthcare Services Group Inc -58.59%$ -58.595 millions
Community Health Systems Inc -60.22%$ -60.215 millions
Pro Dex Inc-66.50%$ -66.496 millions
Hanger inc -67.29%$ -67.286 millions
Electromed Inc -69.47%$ -69.467 millions
Tivity Health Inc -70.69%$ -70.689 millions
Quidel Corporation-71.81%$ -71.807 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FMHS's Profile

Stock Price

FMHS's Financials

Business Description

Fundamentals

Charts & Quotes

FMHS's News

Suppliers

FMHS's Competitors

Customers & Markets

Economic Indicators

FMHS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071